Histologic diagnosis in young women with breast cancer

Breast Cancer Research and Treatment

Volumn 123, Issue SUPPL. 1, 2010, Pages 15-18

  Andreu, Francisco Javier ^a  

^a Servicio de Oncología Médica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; P CADHERIN; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

BASAL CELL CARCINOMA; BREAST CANCER; CANCER CLASSIFICATION; CANCER SCREENING; CELL PROLIFERATION; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; PHENOTYPE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

EID: 77957716720     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1060-3     Document Type: Review

References (24)

1. Tavassoli FA, Devilee P (2003) World Health Organization of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
2. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 1:CAS:528:DC%2BD3sXlsFGntLk%3D 10.1073/pnas.0932692100 12829800
3. J Usary V Llaca G Karaca S Presswala M Karaca X He, et al. 2004 Mutation of GATA3 in human breast tumors Oncogene 23 46 7669 7678 1:CAS:528: DC%2BD2cXotFKjsrY%3D 10.1038/sj.onc.1207966 15361840
4. BS Finlin CL Gau GA Murphy H Shao T Kimel RS Seitz, et al. 2001 RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer J Biol Chem 276 45 42259 42267 1:CAS:528:DC%2BD3MXosVGmsrY%3D 10.1074/jbc.M105888200 11533059
5. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874 1:CAS:528:DC%2BD3MXntVGmsbo%3D 10.1073/pnas.191367098 11553815
6. CM Perou SS Jeffrey M van de Rijn CA Rees MB Eisen DT Ross, et al. 1999 Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci USA 96 16 9212 9217 1:CAS:528: DyaK1MXltVequro%3D 10.1073/pnas.96.16.9212 10430922
7. E de Azambuja F Cardoso G de Castro Jr M Colozza MS Mano V Durbecq, et al. 2007 Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 10 1504 1513 10.1038/sj.bjc.6603756 17453008
8. MC Cheang SK Chia D Voduc D Gao S Leung J Snider, et al. 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 10 736 750 1:CAS:528:DC%2BD1MXmtlyit74%3D 10.1093/jnci/djp082 19436038
9. MC Cheang D Voduc C Bajdik S Leung S McKinney SK Chia, et al. 2008 Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 5 1368 1376 1:CAS:528:DC%2BD1cXislSrs7o%3D 10.1158/1078-0432.CCR-07-1658 18316557
10. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees, et al. 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10.1038/35021093 10963602
11. CH Lin JY Liau YS Lu CS Huang WC Lee KT Kuo, et al. 2009 Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia Cancer Epidemiol Biomarkers Prev 18 6 1807 1814 1:CAS:528:DC%2BD1MXmvF2jsrY%3D 10.1158/1055-9965.EPI-09-0096 19505913
12. CU Ihemelandu LD Leffall Jr RL Dewitty TJ Naab HM Mezghebe KH Makambi, et al. 2007 Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome Ann Surg Oncol 14 10 2994 3003 10.1245/s10434-007-9477-6 17647064
13. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri, et al. 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 18 10393 10398 1:CAS:528:DC%2BD3sXntFynsrk%3D 10.1073/pnas.1732912100 12917485
14. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374 1:CAS:528: DC%2BD2cXmvFSlt7k%3D 10.1158/1078-0432.CCR-04-0220 15328174
15. DJ Slamon B Leyland-Jones S Shak H Fuchs V Paton A Bajamonde, et al. 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 11 783 792 1:CAS:528:DC%2BD3MXisVGktrc%3D 10.1056/NEJM200103153441101 11248153
16. KR Bauer M Brown RD Cress CA Parise V Caggiano 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry Cancer 109 9 1721 1728 10.1002/cncr.22618 17387718
17. MJ Kim JY Ro SH Ahn HH Kim SB Kim G Gong 2006 Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 37 9 1217 1226 1:CAS:528:DC%2BD28XovVWrt7k%3D 10.1016/j.humpath.2006.04.015 16938528
18. E Korsching J Packeisen K Agelopoulos M Eisenacher R Voss J Isola, et al. 2002 Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis Lab Invest 82 11 1525 1533 1:CAS:528:DC%2BD38XosVCnt70%3D 12429812
19. WD Foulkes IM Stefansson PO Chappuis LR Begin JR Goffin N Wong, et al. 2003 Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 19 1482 1485 1:CAS:528:DC%2BD3sXnvVCjtrk%3D 14519755
20. E Honrado J Benitez J Palacios 2005 The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications Mod Pathol 18 10 1305 1320 1:CAS:528:DC%2BD2MXhtVWiu7fP 10.1038/modpathol.3800453 15933754
21. Breast Cancer Linkage Consortium 1997 Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 349 9064 1505 1510 10.1016/S0140-6736(96) 10109-4
22. TA Grushko MA Blackwood PL Schumm FG Hagos MO Adeyanju MD Feldman, et al. 2002 Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers Cancer Res 62 5 1481 1488 1:CAS:528:DC%2BD38Xit1Khu78%3D 11888924
23. ME Robson PO Chappuis J Satagopan N Wong J Boyd JR Goffin, et al. 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 1 R8 R17 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D 10.1186/bcr658 14680495
24. RD Kennedy JE Quinn PG Johnston DP Harkin 2002 BRCA1: mechanisms of inactivation and implications for management of patients Lancet 360 9338 1007 1014 1:CAS:528:DC%2BD38XnsF2ks7o%3D 10.1016/S0140-6736(02)11087-7 12383682